E Fund Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Sell |
14,033
-1,998
| -12% | -$18.7K | 0.01% | 371 |
|
|
2025
Q1 | $197K | Buy |
16,031
+3,428
| +27% | +$42.1K | 0.01% | 364 |
|
|
2024
Q4 | $167K | Buy |
12,603
+1,583
| +14% | +$20.9K | 0.01% | 371 |
|
|
2024
Q3 | $212K | Buy |
11,020
+214
| +2% | +$4.12K | 0.01% | 319 |
|
|
2024
Q2 | $222K | Sell |
10,806
-6,832
| -39% | -$140K | 0.01% | 275 |
|
|
2024
Q1 | $420K | Sell |
17,638
-3,942
| -18% | -$93.8K | 0.03% | 199 |
|
|
2023
Q4 | $466K | Buy |
21,580
+6,986
| +48% | +$151K | 0.03% | 174 |
|
|
2023
Q3 | $212K | Sell |
14,594
-3,433
| -19% | -$49.9K | 0.02% | 250 |
|
|
2023
Q2 | $377K | Buy |
18,027
+1,962
| +12% | +$41K | 0.03% | 184 |
|
|
2023
Q1 | $339K | Buy |
16,065
+2,202
| +16% | +$46.5K | 0.02% | 208 |
|
|
2022
Q4 | $353K | Buy |
13,863
+3,799
| +38% | +$96.7K | 0.03% | 205 |
|
|
2022
Q3 | $242K | Buy |
+10,064
| New | +$242K | 0.02% | 268 |
|